Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

AMX0035 in ALS: long-term survival analysis of the CENTAUR trial 3:40
AMX0035 in ALS: long-term survival analysis of the CENTAUR trial
Sabrina Paganoni • 15 Apr 2021
A new era in the discovery of ALS treatments 0:56
A new era in the discovery of ALS treatments
Sabrina Paganoni • 15 Apr 2021
CNM-Au8 gold nanocatalysts to slow disease progression in ALS 3:11
CNM-Au8 gold nanocatalysts to slow disease progression in ALS
Robert Glanzman • 1 Mar 2021
The perpetual multi-center multi-regimen Healy-ALS Platform trial 0:46
The perpetual multi-center multi-regimen Healy-ALS Platform trial
Robert Glanzman • 1 Mar 2021
Debating controversies in ALS 2:54
Debating controversies in ALS
Ettore Beghi • 27 Oct 2020
COVID-19: managing neurodegenerative diseases in southern Italy 6:13
COVID-19: managing neurodegenerative diseases in southern Italy
Giancarlo Logroscino • 22 Oct 2020
Potential toxins causing sporadic ALS: nitrosamines and hydrazines 2:40
Potential toxins causing sporadic ALS: nitrosamines and hydrazines
Peter Spencer • 19 Oct 2020
Potential environmental triggers of sporadic ALS 2:32
Potential environmental triggers of sporadic ALS
Peter Spencer • 19 Oct 2020
The reconstructed cohort design: tracking rare neurodegenerative diseases 4:40
The reconstructed cohort design: tracking rare neurodegenerative diseases
Giancarlo Logroscino • 22 Oct 2020
Identifying new therapeutic targets for neurodegenerative diseases 1:34
Identifying new therapeutic targets for neurodegenerative diseases
Bart De Strooper • 19 Oct 2020
Cycad toxins driving the ALS-Parkinsonism-Dementia complex 2:40
Cycad toxins driving the ALS-Parkinsonism-Dementia complex
Peter Spencer • 19 Oct 2020
ALS and FTD future research 1:51
ALS and FTD future research
Yuliya Shpilyukova • 17 May 2020
Genetics and ALS 0:48
Genetics and ALS
Rosario Vasta • 25 May 2020
ALS and FTD: current treatment landscape 1:40
ALS and FTD: current treatment landscape
Yuliya Shpilyukova • 17 May 2020
A new prognostic model for ALS 3:31
A new prognostic model for ALS
Rosario Vasta • 25 May 2020
C9orf72 hexanucleotide repeat expansion in ALS and FTD 2:31
C9orf72 hexanucleotide repeat expansion in ALS and FTD
Yuliya Shpilyukova • 17 May 2020
The content of VJNeurology is intended for healthcare professionals